The SOIC Podcast

Wondering how India’s markets and industries are performing? In this episode, we decode Q1 FY26 results like never before — from the broader indices to sector standouts like banking, pharma, healthcare, IT, defence, and transmission. Discover companies delivering 50%+ PAT growth, key macro triggers, RBI’s policy shifts, and the next big themes to watch. Perfect for investors who want insights, not noise.

In this episode, you’ll learn about 7 powerful themes driving India’s growth – pharma distribution, premium SUVs, solar pumps, premium alcohol, gold finance, power transmission, and next-gen manufacturing. From every theme, Within each theme, we discuss companies that are scaling fast and positioned for strong growth in the coming years — along with the key triggers and opportunities over the next 3–4 years.

A must-listen for investors who want to spot the next wave of winners.

Ever wondered which CDMOs are driving growth—and where the hidden risks are? In this episode, we unpack the Q1 FY26 results of leading players, including Ami Organics, Laurus Labs, Neuland Laboratories, Jubilant Pharmova, Piramal Pharma, Syngene International, Hikal Ltd, Blue Jet Healthcare, and Aarti Pharmalabs.

From capex moves and margin trends to valuation caution and IPO red flags, we highlight what really matters for investors. Whether you’re an equity investor or simply curious about India’s fast-evolving pharma outsourcing story, this episode gives you the clarity you need to spot opportunities in a hot, lumpy sector.

In this episode, we break down the current state of India’s NBFC and banking sector to assess whether a true revival is underway. From RBI’s liquidity tightening to rising NPAs, we explore how different lending models are navigating stress. We dive into five key NBFC segments — Gold Loan NBFCs, Commercial Vehicle Lenders, Conglomerate-Backed NBFCs, SME/MSME Lenders, and Microfinance Institutions — to understand asset quality trends, growth challenges, and what lies ahead.

If you're investing in financials, this episode offers a grounded, timely perspective on where the sector really stands.

In this thought-provoking episode, Siddhant Nautiyal from SOIC dives into a real conversation with Ishmohit on today’s confusing market. Is this the start of a new bull run — or are we stuck in a dull, directionless phase?

They unpack it all: the kind of market we’re in, how much macro factors like RBI policy and inflation really matter, how investors should approach recent IPOs, and whether exporters can hold up under global tariffs.

You’ll also hear insights on technical chart signals, which concalls reveal sector trends, and the most important lessons from this cycle — all tied back to timeless SOIC-style frameworks like TVGP.

Siddhant brings the tough questions — and Ishmohit breaks it all down with clarity and depth.

🎯 If you’re a serious long-term investor, this is one conversation you won’t want to miss.

In this episode, we dive deep into one of India's most powerful and underappreciated sectors — the dairy industry. You'll learn how milk moves from rural farms to urban shelves, how regional players build trust with farmers, and why value-added products like cheese, yogurt, and protein are driving the next phase of growth.

We break down:

✅ The full dairy value chain

✅ Why the industry is regional and cyclical

✅ India's top listed and co-operative dairy brands

✅ Where the margins really are

✅ Risks investors must watch

✅ Technical + valuation insights on key stocks

Whether you're an investor, operator, or just curious — this episode will change the way you see your morning milk.

In this episode, we explore Fine Organics — a global leader in emulsifiers and polymer additives. With over 600 products, a pristine balance sheet, and aggressive global capex plans, the company is positioning itself for a major growth comeback after years of stagnancy. We dive into its competitive edge, market presence across 80+ countries, and the key risks and triggers that could define the next phase of this specialty chemicals player.

Perfect for investors, analysts, and business enthusiasts who want a clear, structured view of this speciality chemicals player.

Welcome to today’s deep dive on the global and Indian defence sector — where geopolitics, military innovation, and stock market opportunities come together.

In this episode, we explore:

• Why wars happen and how global power is shifting

• How modern warfare — like drones and cyber tech — is replacing tanks and jets

• India’s growing role in defence exports, reforms, and key companies leading this change

• The value chain of the defence industry, plus we explore valuations, technical trends, and risk factors investors should know

• And yes — we break down several top Indian defence companies shaping the future

Whether you're a student, investor, or just curious about how defence is evolving, this episode is packed with insights for listeners like you.

Let’s get into it. 🎙️

In this episode, we analyze how Indian capital market companies like Motilal Oswal, Edelweiss, and JM Financial are shifting from transaction-based income to more stable, recurring revenue models like wealth management and asset management. We also discuss how past mistakes in wholesale lending are being corrected, and explore the industry’s long-term growth potential, key risks, and valuation outlook.

In this episode, we dive deep into two contract development and manufacturing (CDMO) businesses—Aarti Pharma Labs and Jubilant Pharma—that are riding strong structural trends.
🔬 Learn how the pharma value chain works
📈 Understand key mental models behind successful CDMOs
🚀 Discover growth drivers, J-curve business models & risk factors
💡 Bonus: How these companies are shifting from cash cow APIs to scalable CDMO businesses

Perfect for investors looking to identify the next big wave in healthcare manufacturing.